These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11896081)

  • 1. The bioavailability of mupirocin in nasal secretions in vitro.
    Hill RL
    J Clin Pathol; 2002 Mar; 55(3):233-5. PubMed ID: 11896081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The in-vitro activity of povidone-iodinecream against Staphylococcus aureus and its bioavailability in nasal secretions.
    Hill RL; Casewell MW
    J Hosp Infect; 2000 Jul; 45(3):198-205. PubMed ID: 10896798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquisition of high-level mupirocin resistance in CoNS following nasal decolonization with mupirocin.
    Hetem DJ; Vogely HC; Severs TT; Troelstra A; Kusters JG; Bonten MJ
    J Antimicrob Chemother; 2015 Apr; 70(4):1182-4. PubMed ID: 25538164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of PEGylated salmon calcitonin in nasal mucosa.
    Na DH; Youn YS; Park EJ; Lee JM; Cho OR; Lee KR; Lee SD; Yoo SD; DeLuca PP; Lee KC
    J Pharm Sci; 2004 Feb; 93(2):256-61. PubMed ID: 14705183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of chlorhexidine retention in different oral sites using matrix-assisted laser desorption/ionization-time of flight mass spectrometry.
    Reda B; Hollemeyer K; Trautmann S; Hannig M; Volmer DA
    Arch Oral Biol; 2020 Feb; 110():104623. PubMed ID: 31830639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An intranasal irritation assessment of antibacterial ointment alone or in combination with mupirocin versus Bactroban Nasal in rabbits.
    Faqi AS; Bell SJ; Gill S; Colagiovanni DB
    Regul Toxicol Pharmacol; 2009 Oct; 55(1):28-32. PubMed ID: 19497343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Quantitative determination of protein, albumin, and antibiotics in nasal secretions of healthy probands (author's transl)].
    Giebel W; Schönleber KH; Breuninger H; Ullmann U
    Arch Otorhinolaryngol; 1979; 225(2):149-59. PubMed ID: 533454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Penetration of enrofloxacin into the nasal secretions and relationship between nasal secretions and plasma enrofloxacin concentrations after intramuscular administration in healthy pigs.
    Bimazubute M; Cambier C; Baert K; Vanbelle S; Chiap P; Albert A; Delporte JP; Gustin P
    J Vet Pharmacol Ther; 2010 Apr; 33(2):183-8. PubMed ID: 20444043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bradykinin metabolism in rat and sheep nasal secretions.
    Chung FY; Donovan MD
    J Pharm Sci; 1995 Jul; 84(7):829-34. PubMed ID: 7562432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlorhexidine and mupirocin susceptibilities in methicillin-resistant Staphylococcus aureus isolates from bacteraemia and nasal colonisation.
    Muñoz-Gallego I; Infiesta L; Viedma E; Perez-Montarelo D; Chaves F
    J Glob Antimicrob Resist; 2016 Mar; 4():65-69. PubMed ID: 27436397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of preoperative conjunctival bacterial flora with the use of mupirocin nasal ointment.
    Alexandrou TJ; Hariprasad SM; Benevento J; Rubin MP; Saidel M; Ksiazek S; Thompson K; Boonlayangoor S; Mieler WF
    Trans Am Ophthalmol Soc; 2006; 104():196-201. PubMed ID: 17471340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of spiramycin concentration by bromhexin in the bovine nasal secretions.
    Escoula L; Larrieu G; Camguilhem R
    Ann Rech Vet; 1981; 12(3):317-20. PubMed ID: 7344562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nasal concentrations of fusafungin following administration of a dosage aerosol (Locabiosol)].
    Rohdewald P; Lohmann A
    Laryngol Rhinol Otol (Stuttg); 1987 Aug; 66(8):416-9. PubMed ID: 3669830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routine identification of microorganisms by matrix-assisted laser desorption ionization time-of-flight mass spectrometry: Success rate, economic analysis, and clinical outcome.
    Ge MC; Kuo AJ; Liu KL; Wen YH; Chia JH; Chang PY; Lee MH; Wu TL; Chang SC; Lu JJ
    J Microbiol Immunol Infect; 2017 Oct; 50(5):662-668. PubMed ID: 27426930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of clarithromycin on nasal mucus properties in healthy subjects and in patients with purulent rhinitis.
    Rubin BK; Druce H; Ramirez OE; Palmer R
    Am J Respir Crit Care Med; 1997 Jun; 155(6):2018-23. PubMed ID: 9196110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF) enhance antimicrobial stewardship efforts in the acute care setting?
    Tamma PD; Tan K; Nussenblatt VR; Turnbull AE; Carroll KC; Cosgrove SE
    Infect Control Hosp Epidemiol; 2013 Sep; 34(9):990-5. PubMed ID: 23917918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local application of mupirocin ointment in the eradication of Staphylococcus aureus from nasal mucosa in patients on chronic hemodialysis.
    Ladavac R; Vranić-Ladavac M; Jerin L
    Acta Med Croatica; 1997; 51(4-5):211-3. PubMed ID: 9473800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mupirocin reduces ciliary beat frequency of human nasal epithelial cells.
    Birk R; Aderhold C; Wenzel A; Eschenhagen T; Kramer B; Hörmann K; Stuck BA; Sommer JU
    Eur Arch Otorhinolaryngol; 2016 Dec; 273(12):4335-4341. PubMed ID: 27342406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical Decolonization Does Not Eradicate the Skin Microbiota of Community-Dwelling or Hospitalized Adults.
    Burnham CA; Hogan PG; Wallace MA; Deych E; Shannon W; Warren DK; Fritz SA
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7303-7312. PubMed ID: 27671074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TXA497 as a topical antibacterial agent: comparative antistaphylococcal, skin deposition, and skin permeation studies with mupirocin.
    Dorrani M; Kaul M; Parhi A; LaVoie EJ; Pilch DS; Michniak-Kohn B
    Int J Pharm; 2014 Dec; 476(1-2):199-204. PubMed ID: 25263100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.